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INTRODUCTION 
 
Anoxic fermentation of different carbon sources is rapidly gaining 
momentum in biotechnological setups aimed at obtaining reduced 
biochemicals. Relevant examples in this sense include (but are 
certainly not limited to) the production of polyhydroxyalkanoates 
(PHAs) [1,2], ethanol [3,4], 1,3-propanediol (1,3-PDO) [5,6], 
succinate [7], and D-lactate [8]. These reduced biochemicals possess 
great commercial interest, and are usually synthesized by different 
microorganisms through the activity of both native and heterologous 
pathways. In spite of the fact that several bacterial species are 
currently being used in biotechnological setups, E. coli remains as the 
microbial cell factory (MCF) par excellence, mainly because this well- 
characterized enterobacterium can easily and rapidly grow on cheap 
substrates and can be modified as desired through a broad variety of 
molecular  tools. As   fermentation   technologies   designed  for  the 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
production of bulk bioproducts need further innovation to became 
economically and environmentally sound [9], there is an increasing 
interest in methodologies that optimize the production of 
biochemicals, such as those listed above, according to both market 
demands and bioprocess energy requirements. It has been proposed 
that the most probable avenue for future improvements of these 
strategies will rely on a combination of efficient fermentation 
processes and in the manipulation of the MCF metabolism employing 
metabolic engineering strategies. 
Metabolic manipulations to enhance the synthesis of metabolic 
products include several approaches to increase the availability of 
substrates needed for its formation and/or to eliminate competing 
pathways that lead to the formation of by-products, which sometimes 
conduces to undesired phenotypes. An alternative strategy that has 
been scarcely exploited for the design and optimization of MCFs is 
the network-wide manipulation of metabolic fluxes by means of 
mutations in global regulators. In fact, and depending on 
environmental circumstances, this approach can outperform the more 
traditional metabolic engineering strategy based on the direct 
manipulation of the gene(s) involved in the pathway(s) of interest. In 
the present mini-review, we summarize the recent advances and 
current state on the use of redox and/or regulatory E. coli mutants as 
MCFs for the production of reduced biochemicals and recombinant 
proteins. In the first part, we present some general aspects of the 
microbial metabolism that are subjected to control by environmental 
conditions through the regulation exerted by two-component signal 
transduction systems, namely ArcBA and CreBC. The application of 
targeted mutants in these regulatory systems in processes aimed at the 
synthesis of PHAs, under conditions with restricted O2 supply, is then 
presented along with other examples of products with commercial 
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value. Future directions for improvement of these redox MCFs are 
finally discussed under the light of synthetic biology, computer-aided 
modeling, and other in silico strategies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REGULATION OF CENTRAL METABOLIC 
PATHWAYS IN E. coli BY ENVIRONMENTAL 
CONDITIONS: NEW LESSONS FOR AN OLD 
HISTORY 
 
As metabolic engineering approaches become more and more 
complex in the pursuit of the ideal MCF for the production of 
reduced biochemicals, the need of a complete understanding of cell 
physiology and metabolic network operativity under micro-oxic and 
anoxic growth conditions also becomes apparent. Recent genome-
wide models revealed new aspects of the regulation of these pathways, 
which have a deep impact in the energy and redox homeostasis of the 
cells and, consequently, on the strategies implemented in order to 
manipulate these traits. A brief summary of the core E. coli 
metabolism is presented below, and the different pathways for D-
glucose utilization are depicted in Fig. 1 along with some key 
regulatory checkpoints within the native metabolic network. 
The initial steps in the catabolism of D-glucose, the preferred 
carbon source of E. coli and the substrate most often used in 
biotechnological setups, are independent of O2 availability. D-Glucose 
is split into the Embden-Meyerhof-Parnas (EMP) pathway and the 
pentose phosphate (PP) pathway at the D-glucose-6-P branching 
point [10]. The oxidation of D-glucose-6-P to D-ribose-5-P via the 
PP pathway generates reducing equivalents (i.e., NADPH) that are 
mostly used for biosynthesis and to quell stressful conditions. 
Degradation of D-glucose-6-P by the EMP pathway, in contrast, 
generates pyruvate, which under oxic conditions is decarboxylated by 
the pyruvate dehydrogenase complex to produce acetyl-coenzyme A 
(CoA), NADH, and CO2 [11,12]. Oxidation of acetyl-CoA in the 
tricarboxylic acid (TCA) cycle generates electron carriers (i.e., NADH 
and FADH2), channeled into the electron-transport chain to finally 
reduce O2 to H2O, creating a H+ gradient used to generate ATP by 
means of ATP synthase. D-Glucose is completely oxidized to CO2 
and H2O to conserve energy during oxic respiration, thus giving the 
maximum ATP yield. 
When O2 is not available, E. coli undergoes anoxic respiration as 
long as an alternative electron acceptor is present in the surrounding 
environment [13]. Electron-transport chains of E. coli comprise 
dehydrogenases and terminal oxidases linked to a complex 
(ubi)quinone pool [14]. The presence of a particular electron acceptor 
under anoxic conditions results in the transcriptional activation of 
specific oxido-reductases and dehydrogenases and, concomitantly, in 
the repression of alternative oxido-reductases [14,15]. This 
transcriptional control is exerted by global regulatory proteins (e.g., 
Fnr, ArcA, NarQ, NarX), which respond to changing levels of 
electron acceptors (O2 in the case of Fnr and ArcA, and nitrate in the 
case of NarQ and NarX) to maximize metabolic efficiency ([10,14-
17], see also next section). 
In the absence of any terminal acceptor, substrate-level 
phosphorylation is used for energy production and redox homeostasis 
is achieved by transferring electrons from reducing equivalents to an 
internal electron acceptor, such as pyruvate or acetyl-CoA [18]. 
Mixed acid fermentation [19,20] thereby generates the overflow 
metabolites acetate, ethanol, formate, D-lactate, and succinate. Under 
anoxic conditions, pyruvate generated through the EMP pathway is 
processed by the radical enzyme pyruvate formate-lyase (PFL), 
leading to the production of acetyl-CoA and formate (with a lesser 
contribution of the mostly aerobic pyruvate-dehydrogenase complex 
[21,22]). Expression of the pfl genes is controlled by several 
transcription factors [23-28], and PFL is mainly active in the absence 
of O2 [29], although it can contribute to acetyl-CoA formation under 
micro-oxic conditions [30,31]. Formate produced by PFL can be 
converted to H2 and CO2 by formate-hydrogen lyase [32-34]. On the 
other hand, acetyl-CoA produced by PFL can be converted into 
ethanol or acetate. Reduction of acetyl-CoA to ethanol is catalyzed by 
an acetaldehyde/alcohol dehydrogenase (AdhE), and production of 
acetate from acetyl-CoA generates ATP by substrate-level 
phosphorylation [35]. This two-step reaction is catalyzed by the 
sequential action of the enzymes phosphotransacetylase (Pta) and 
acetate kinase (AckA), encoded by the ackA-pta operon. The 
metabolic fate of acetyl-CoA largely depends on the amount and type 
of the carbon source used and the availability of reducing equivalents. 
As mentioned above, minor amounts of D-lactate and succinate are 
also produced during mixed acid fermentation. D-Lactate is formed 
by the reduction of pyruvate by the NADH-dependent D-lactate 
dehydrogenase (LdhA) [36]. Succinate is produced by the reductive 
decarboxylation of P-enol-pyruvate to fumarate by fumarate 
Figure 1. Simplified representation of the oxic and anoxic pathways for 
D-glucose catabolism in E. coli. Oxic pathways are sketched to the right of 
the outline, and anoxic pathways are represented to the left along with 
the main fermentation metabolites formed (in red). The initial catabolic 
steps of D-glucose through the Embden-Meyerhof-Parnas pathway, which 
are independent of the presence of O2, are indicated by a dashed vertical 
arrow. Central metabolites relevant for the production of the reduced 
biochemicals discussed in the text are shown in boldface. The double 
arrow representing the conversion of pyruvate into acetyl-CoA illustrate 
the activity of either the pyruvate dehydrogenase complex (mostly under 
oxic conditions, right), or pyruvate-formate lyase (mostly under anoxic 
conditions, left). Secretion of fermentation metabolites and active H+ 
pumping are indicated by red arrows. Slanted arrowheads identify 
metabolic steps that are subjected to regulation by the ArcBA system (red) 
and/or the CreBC system (purple). Abbreviations are as follows: NDHI and 
NDHII, NADH:ubiquinone oxido-reductases I and II, respectively; Q, 
(ubi)quinone/(ubi)quinol; Cyt d and Cyt o; cytochromes d and o oxidases, 
respectively; CoA, coenzyme A; TCA cycle, tricarboxylic acid cycle. Nota 
bene, although the TCA cycle is depicted as an entirely oxic sequence of 
reactions in this scheme, the reductive branch, active under conditions 
with restricted O2 supply, produces succinate as a fermentation 
metabolite. 
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reductase, as a result of the repression of the oxidative branch in the 
TCA cycle [37,38]. The presence of alternative carbon sources in the 
culture medium also alters the pattern of metabolic pathways active 
within the cell. Although not extensively considered in the present 
mini-review, some interesting approaches designed for metabolic 
engineering applications involve the use of glycerol (see next sections), 
pentoses, and short-chain fatty acids [39-43]. 
All the above mentioned metabolic pathways are ultimately 
regulated by the availability of O2, and the delicate redox and energy 
balances are tightly controlled at several levels. On top of them all, 
transcriptional regulation constitutes the predominant mechanism 
whereby the activity of the relevant pathway(s) is temporally and 
spatially coordinated in order to meet homeostasis. The next section 
describes the main patterns of global regulation that ultimately ensure 
the network-wide adjustment of metabolic pathway activity. 
 
REGULATORY TASKS OF THE ArcBA AND CreBC 
TWO-COMPONENT SYSTEMS ON THE CENTRAL 
METABOLIC PATHWAYS OF E. coli 
 
Signal transduction pathways are involved in intercellular 
interactions and communication of environmental conditions to the 
interior of the cell. The final outcome of such a signaling pathway is 
the activation of specific transcription factor(s) that, in turn, 
control(s) gene expression. Regulation of gene expression is a very 
complex process, and transcriptional regulators can be subdivided in 
global and local regulators depending on the number of operons (i.e., 
regulons) they control. Global regulators control the expression of a 
vast number of genes, which might be physically scattered along the 
genome and normally belong to different functional clusters. 
According to the data available in the EcoCyc database [44], E. coli 
K12 strain MG1655 contains forty master (i.e., global) regulators and 
 factors. Perhaps surprisingly, only seven global regulators control 
the expression of ca. half of all genes; i.e., ArcA, Crp, Fis, Fnr, Ihf, 
Lrp, and NarL [45]. In contrast to these global regulators, local 
regulators control the expression of only a few genes, and ca. one-fifth 
of all the transcriptional regulators so far described control the 
expression of just one or two genes. 
O2 functions as an electron acceptor and substrate for catabolism 
in a wide variety of bacteria, and most facultative anaerobe 
microorganisms are able to thrive across a wide range of O2 
availability conditions. As hyperoxic conditions may produce adverse 
effects in bacteria by inducing oxidative stress, micro-aerobic and 
facultative anaerobic bacteria have evolved elaborate sensing and signal 
transduction mechanisms in order to adapt their metabolism in 
response to O2 availability [46]. As explained before, the choice of 
energy generation pathways is determined by the accessibility to 
electron acceptors. Sophisticated and often interrelated regulatory 
networks switch the expression of these pathways on and off as 
needed [13,15]. In the hierarchical regulation system for energy 
transduction, adaptive responses to O2 are mainly coordinated by the 
Fnr and ArcA global regulators [47]. The transcriptional regulation 
exerted by Fnr is mostly related to strict anoxic conditions, and its 
effects have been reviewed elsewhere [48,49]. 
The ArcBA (anoxic redox control) two-component signal 
transduction system modulates at the transcriptional level the 
expression of many operons according to the redox state of the 
environment [50-53]. ArcB is a transmembrane sensor kinase which 
under anoxic or micro-oxic conditions undergoes stable 
phosphorylation and then transphosphorylates the response regulator 
ArcA. The main targets for repression by ArcAP are the genes that 
encode enzymes involved in oxic respiration. On the other hand, the 
cytochrome d oxidase, with high O2 affinity, and genes encoding 
fermentation enzymes such as PFL, are activated under anoxic 
conditions. The effects of ArcAP on the transcription patterns has 
been analyzed at the whole-genome level, and it was shown that many 
other genes, far beyond those directly involved in redox metabolism, 
are putative targets for ArcA regulation. In fact, it was found that ca. 
150 operons involved in energy metabolism, nutrients transport, 
bacterial survival, catabolism of diverse carbon sources, and 
transcriptional regulation, were included in the Arc modulon. Later 
on, statistical analysis of genome-wide DNA microarrays led to the 
striking conclusion that the transcription of at least 1,139 genes of E. 
coli could be either directly or indirectly regulated by ArcAP [54]. 
CreBC (carbon source responsive) is also a global sensing and 
regulation system responsive to both the carbon source and the O2 
availability [55]. The cre locus comprises creABCD and was formerly 
known as phoM locus. While creA is a hypothetical open reading 
frame and creD, also known as cet, encodes an inner-membrane 
protein of unknown function; creB and creC encode a two-
component system, i.e., a cytoplasmic regulator and a sensor kinase, 
respectively. Following the discovery of CreBC and its recognition as 
a sensing/regulatory pair, genes modulated bona fide by this system 
proved very elusive. Based on genome-wide sequence analysis and 
using bioinformatic tools, Avison et al. [55] were able to define a so-
called cre tag sequence, to which CreB is known to bind in vitro, in 
order to describe the Cre regulon. So far, the Cre regulon comprises 
seven genes activated by CreBC (among them, ackA-pta, talA, and 
creD) and one repressed (malE), and the expression pattern of these 
genes responds to the nature of the carbon source used to grow the 
cells and the O2 availability. Indeed, expression of genes modulated by 
CreBC is activated under fermentative growth conditions using 
glycolytic carbon sources, as well as under oxic conditions with low-
molecular-weight fermentation products as the substrate, such as 
formate or pyruvate. Yet, very little is known about this system and 
the extent of its regulation on the central metabolism of E. coli. 
The intracellular distribution of metabolites (and, consequently, 
the phenotypic traits of the cell) is regulated at several levels. 
Transcriptional regulation is thought to be the principal type of 
regulation in bacteria, yet the way in which it controls metabolic 
fluxes is not well understood. Several studies have recently tried to 
clarify the correlation between metabolic networks and transcriptional 
control by means of metabolic flux analysis in global regulatory 
mutants. A breakthrough in fluxome quantification strategies was the 
use of 13C-substrates, which proceed through the entire metabolic 
network and propagate their labeling pattern into the pools of 
downstream metabolites, thus allowing to calculate the flux(es) 
through the pathway(s) at stake [56-59]. Since ArcA has been 
identified as a major global regulator, several works were dedicated to 
unravel its role in controlling the E. coli central metabolism. One of 
them dealt with different global regulatory mutants of E. coli grown 
on D-glucose batch cultures [60]. This study provided novel insights 
into the regulation brought about by the ArcBA system, 
demonstrating that, unexpectedly, the control of fully oxic and anoxic 
fluxes through the TCA cycle was exerted by ArcA in an ArcB-
independent fashion. 13C-labeling experiments were also performed in 
∆arcA and ∆fnr mutants in D-glucoselimited chemostat cultures 
[61]. These mutations were shown to affect the flux distribution in 
the core metabolic pathways, mainly through the availability of 
reducing equivalents. 
As both ArcBA and CreBC regulate the expression of genes 
encoding enzymes of the central catabolic pathways (see 
Supplementary Table S1 for details), the next relevant question was 
whether there is a shared control of metabolism by the two systems. 
E. coli redox mutants 
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13C-Based metabolic flux analysis conducted for a wild-type E. coli 
strain and its isogenic ∆creB, ∆arcA, and ∆creB ∆arcA derivatives in 
D-glucose- and O2-limited chemostat experiments demonstrated that 
both ArcBA and CreBC exert an important influence on central 
carbon catabolic fluxes [62]. In particular, it was observed that both 
the P-enol-pyruvate and the acetyl-CoA metabolic nodes are subjected 
to regulation by CreB and ArcA, strongly influencing the fate of the 
carbon atoms at these branching points. Interestingly, the first steps 
on D-glucose catabolism did not seem to be affected, and most of the 
carbon source was channeled through the EMP pathway without 
evident differences between the wild-type strain and its mutant 
derivatives. 
At this point, it is relevant to consider that the genotype-
phenotype relationships in regulatory mutants are usually very 
complex, and the deletion of global regulators may have an impact 
beyond the redox and catabolic traits of the cells. The combined 
approaches discussed in this section for the analysis of regulatory 
mutants are relevant since deletion of global regulatory genes is 
expected to affect the entire cellular and metabolic landscape in a 
rather difficult-to-predict fashion. Moreover, possible cross-talk 
mechanisms between these two-component systems [63,64] could 
also contribute to the complex biochemical signalization in the 
resulting MCFs, and modulation of the Arc and/or Cre signalization 
by different levels of fermentation metabolites [65] cannot be ruled 
out. One way or the other, the results of the studies discussed above 
underscored the potential of arc and cre mutants as MCFs, and they 
were utilized for the production of different reduced biochemicals, as 
detailed in the next sections. 
 
BACTERIAL POLYHYDROXYALKANOATES 
 
PHAs are synthesized naturally by a wide variety of bacterial 
species as a reserve material for carbon and energy [2,66]. These 
ubiquitous polymers attract increasing industrial interest as renewable, 
biodegradable, biocompatible, and extremely versatile thermoplastics 
[2]. In fact, PHAs are the only H2O-proof thermoplastic materials 
which are also fully biodegradable in both oxic and anoxic 
environments. Two classes of PHAs are distinguished according to 
their monomer composition: short-chain length (SCL) PHAs, and 
medium-chain length (MCL) PHAs. SCL-PHAs are composed of 3-
hydroxyacid monomers with a chain length of three to five carbon 
atoms, such as poly(3-hydroxybutyrate) (PHB, the most common and 
widely distributed PHA in nature); whereas MCL-PHAs contain 3-
hydroxyacid monomers with six to sixteen carbon atoms. All of these 
polymers are optically active R-(—)-compounds, and give rise to 
isotactic carbon chains. The structural versatility of PHAs is partly 
due to the wide substrate range of the polymer-synthesizing enzymes, 
and it endows PHAs with an extended spectrum of mechanical and 
physical properties, a clear advantage vis-à-vis to other bioplastics. 
More than 200 different monomer constituents have been found so 
far in these polymers [67]. PHB is synthesized from acetyl-CoA in a 
three-step pathway (Fig. 2A), that uses NADPH as cofactor. 
The design and development of efficient MCFs for PHA 
production received much attention in the last few decades. Although 
different microorganisms have been exploited for polymer production, 
E. coli is most often used as the biocatalyst [68] as it does not 
accumulate PHAs naturally, thus offering the flexibility to manipulate 
both native and heterologous pathways for PHA synthesis. Current 
high-yield bioprocesses for the synthesis of PHAs require fully oxic 
conditions, meaning that they are high energy-consuming processes. 
The environmental impact of replacing oil-derived plastics with 
biopolymers has been the subject of several studies, among them, 
those regarding technical-scale PHB production in bioreactors [69]. 
The main conclusion of these studies is that when the total amount of 
energy invested is taken into consideration [i.e., the energy needed for 
sterilization, aeration, and agitation (both in the bioreactor and 
downstream processing), as well as the energy for the production of 
agricultural feed-stocks used as carbon sources], the environmental 
performance of PHAs equals that of petrochemical polymers. This 
situation clearly calls for alternative bioprocesses and biocatalysts to 
meet the technical and environmental requirements of a sound 
production process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Metabolic networks are the most obvious targets for rational 
design of sustainable PHA production processes. As stated above, E. 
coli arc mutants are unregulated for respiration under micro-oxic 
conditions. Some enzymes of the TCA cycle are not repressed and the 
pool of reducing equivalents is elevated, and thus available to be 
funneled into reduced biochemicals. The PHB biosynthetic genes 
from Azotobacter sp. strain FA8 [70] were introduced in a arcA 
strain, and the polymer accumulation was evaluated under micro-oxic 
conditions in a semi-synthetic medium containing D-glucose as the 
carbon source. A PHB content of ca. 35% (w/w) was attained in 
such a redox mutant, while the wild-type strain failed to produce PHB 
under the same culture conditions [71]. Within the same conceptual 
framework, PHA synthesis was evaluated in E. coli CT1061, an arcA 
and creC constitutive mutant. The latter mutation confers enhanced 
carbon source consumption, while retaining the markedly reducing 
intracellular environment typical of arc mutants (with a 
NADH/NAD+ ratio of ca. 1 mol/mol) [72]. E. coli CT1061 
actually outperformed cre and arc individual mutants as a redox MCF. 
Increased PHB yields on substrate were observed in D-glucose- or 
glycerol-supplemented semi-synthetic media [73], especially in micro-
oxic fed-batch cultures with glycerol supplementation. Being the main 
by-product of the biodiesel industry, glycerol became a cheap 
substrate for bioprocesses in the last few years. Since C atoms are in a 
more reduced state than those in hexoses, the use of glycerol as a 
biotechnological substrate is especially attractive in bioprocesses 
Figure 2. Biosynthetic pathways of two model reduced biochemicals, 
poly(3-hydroxybutyrate) and 1,3-propanediol. Biochemical steps that 
consume reducing equivalents are highlighted in blue. Abbreviations are 
as follows: CoA, coenzyme A; PhaA, 3-ketoacyl-CoA thiolase; PhaB, 
acetoacetyl-CoA reductase; PhaC, poly(3-hydroxyalkanoate) synthase; 
DhaB, glycerol dehydratase; DhaT, 1,3-propanediol oxidoreductase. In 
most of the E. coli recombinants described in the text, the phaBAC genes 
were obtained from Azotobacter sp. strain FA8 [70]. 
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designed to produce reduced biochemicals [74,75]. The micro-oxic 
fed-batch cultures afore mentioned allowed a 2.6-fold increase in the 
PHB volumetric productivity when compared to batch cultures. After 
60 h, biomass and PHB concentrations reached 21.17 and 10.81 g/L, 
respectively, resulting in a PHB content of 51% (w/w) [76]. Ethanol 
was co-produced as a valuable by-product of this process [77], 
making it even more interesting in terms of sustainability, as two 
industrially-relevant reduced biochemicals were obtained from 
glycerol, both intracellularly (PHB) and extracellularly (ethanol). 
 The main goal of a successful heterologous expression system 
based on plasmids is to achieve the highest tolerable protein or 
metabolite yield and thus to walk the thin line between high levels of 
heterologous gene expression and the metabolic capacity of the host. 
An unexpected (and most welcome) trait of MCFs bearing arc and cre 
mutations is an enhanced ability to maintain plasmids that encode the 
biosynthetic genes for reduced biochemicals (e.g., ethanol and PHB), 
even in the absence of the selective pressure imposed by addition of 
antibiotics [78]. This side effect was shown to be mostly related to 
the capacity enabled by the plasmid-encoded bioreactions to 
regenerate NAD(P)+, needed to continue cell growth. 
Another target of global regulation exploited for the heterologous 
accumulation of PHB in E. coli is the AtoSC two-component system, 
which regulates the catabolism of short-chain fatty acids. Theodorou 
et al. [79] recently demonstrated that PHB synthesis from D-glucose 
is impaired in a atoSC and atoDAEB mutant, and that this 
phenotype can be restored by ectopic expression of Ato components 
in the recombinants. The authors hinted an important role of the 
AtoSC system in polymer accumulation and also proposed that this 
regulatory system could be an important target for metabolic 
engineering manipulations. In a former study, Pettinari et al. [80] 
proposed the use of a transcriptional activator of the ato genes from 
Bacillus megaterium as an elegant strategy to obtain different types of 
PHAs in recombinant E. coli MCFs. 
A different approach was the use of anoxic promoters to drive the 
transcription of the pha genes from Cupriavidus necator in E. coli 
recombinants under conditions with restricted O2 supply [81]. 
Among the nine native promoters tested, PadhE was the most effective 
in promoting micro-oxic PHB synthesis. The same research group 
recently reported the construction of an E. coli recombinant that 
carries the pha genes from C. necator, as well as the genes encoding 
hydrogenase 3 and/or acetyl-CoA synthetase [82]. The resulting 
strain had the advantage of co-producing PHB and H2 under micro-
oxic conditions in a synthetic medium containing D-glucose and 
acetate as the carbon sources. 
 
1,3-PROPANEDIOL 
 
1,3-PDO is used in many synthetic reactions, particularly as a 
monomer for condensations to produce polyesters, polyethers, and 
polyurethanes [83]. Polymers made with this compound are 
biodegradable and have enhanced chemical properties, such as higher 
light stability and solubility [6]. 1,3-PDO is primarily produced 
through chemical synthesis from petroleum derivatives (acrolein and 
ethylene) in processes that involve high pressure and temperature, but 
it can also be obtained by microbial fermentation, a more 
environmentally-favorable process that has lower costs, especially 
considering its production from glycerol, the abundant by-product of 
the biodiesel synthesis [84]. 1,3-PDO was originally identified by 
August Freund in a glycerol fermentation process with a mixed culture 
containing Clostridium pasteurianum [85], and was later found to be 
produced by the fermentation of glycerol by many Gram-positive and 
Gram-negative bacteria, including Citrobacter, Clostridium, 
Enterobacter, Klebsiella, and Lactobacillus species [86]. As the anoxic 
growth on glycerol generates an excess of reducing equivalents, it 
causes a redox imbalance. In order to meet redox homeostasis, cells 
synthesize products that serve as an electron sink, such as 1,3-PDO. 
This molecule is synthesized in two steps: [i] dehydrogenation of 
glycerol to 3-hydroxypropionaldehyde, and [ii] an NADH-dependent 
reduction of this intermediate to 1,3-PDO, that is secreted into the 
medium [86,87] (Fig. 2B). In microorganisms that produce 1,3-PDO 
naturally, the enzymes involved in glycerol metabolism are a glycerol 
dehydratase, a 1,3-PDO oxidoreductase, a glycerol dehydrogenase, 
and a dihydroxyacetone phosphate kinase. These enzymes are encoded 
in the dha operon, which has been characterized in K. pneumoniae, C. 
freundii, and C. butyricum [6]. 
Many natural 1,3-PDO producers are not suitable for industrial 
production because of their particular culture conditions and, in the 
case of pathogens, because special safety precautions are required [5]. 
For these reasons, there has been recent interest in converting glycerol 
to 1,3-PDO by recombinant E. coli strains. Such MCFs also permit 
the study of the effects of different mutations in genes involved in 
metabolism and global regulators in order to improve the synthesis of 
1,3-PDO. Several research groups have reconstructed the 1,3-PDO 
pathway in E. coli, normally containing genes from K. pneumoniae or 
C. butyricum [88,89]. The highest 1,3-PDO production yield with 
glycerol as the sole carbon source reported so far was in a 
recombinant E. coli strain expressing dhaB1 and dhaB2 from C. 
butyricum, which encode the vitamin B12-independent glycerol 
dehydratase DhaB1 and its activating factor, DhaB2, respectively, 
tandemly arrayed with yqhD from E. coli, which encodes the 1,3-
PDO oxidoreductase isoenzyme YqhD, an NADPH-dependent 
dehydrogenase [90].  
Generally, it can be considered that availability of NADH is one 
of the main factors limiting the production of 1,3-PDO [5]. Several 
metabolic manipulations have been performed in natural producers to 
optimize the synthesis of 1,3-PDO. For example, in K. pneumoniae 
the reductive glycerol pathway has been enhanced, and the oxidative 
glycerol pathway or competing metabolite pathways have been 
eliminated, increasing 1,3-PDO yields [84]. Another strategy involves 
the manipulation of cofactor availability. In K. oxytoca, this has been 
achieved by introducing a formate dehydrogenase from Candida 
boidinii to regenerate NADH [89]. On the other hand, manipulation 
of redox metabolism in E. coli can be achieved using mutations redox 
regulators, such as ArcA, to enhance the synthesis of reduced 
metabolites [91]. This strategy has also been applied to increase the 
availability of reducing equivalents for the synthesis of 1,3-PDO in E. 
coli recombinants containing multiple genetic modifications [92]. 
 
RECOMBINANT PROTEIN PRODUCTION 
 
Several E. coli strains have been examined as potential MCFs to 
produce recombinant proteins at high titres [93], most often in high-
cell-density cultures. A comprehensive overview of the main E. coli 
strains used in recombinant protein production processes and their 
characteristics has been recently published by Waegeman and Soetaert 
[94]. Although E. coli B and E. coli K12 are equally used as hosts for 
recombinant protein production (ca. 47% and 53%, respectively), E. 
coli BL21 is by far the most commonly used MCF (ca. 35%) in 
academia [95,96]. This figure is probably even higher in industrial 
setups. 
Acetate formation in E. coli cultures grown under either oxic or 
micro-oxic/anoxic conditions still represents a major problem in the 
industrial application of this microorganism [35,97,98]. As hinted 
before, acetate is mostly produced when respiratory pathways are 
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saturated and NADH can no longer be re-oxidized [99]. This, in 
turn, causes a shunt in the main catabolic pathways by re-directing 
carbon precursors into acetate (the synthesis of which does not 
generate NADH, in contrast with the four molecules of NADH 
generated by each turn of the TCA cycle, Fig. 1), and thus allowing to 
achieve redox homeostasis. A plethora of different strategies have been 
devised to increase recombinant protein formation and to decrease 
acetate formation, including optimization of the bioprocess 
conditions as well as metabolic engineering of production hosts 
[100]. These attempts can be categorized in three main classes: [i] 
deleting genes involved in acetate formation, [ii] avoiding overflow 
metabolism by limiting D-glucose uptake via alteration of the degree 
of oxidation of the carbon source, applying alternative feeding 
strategies, or by engineering the D-glucose uptake system, and [iii] 
circumventing overflow metabolism by re-directing central metabolic 
fluxes and preserving sufficient precursors for amino acids synthesis, 
the actual building blocks of proteins. 
Acetate has been postulated to be a potential signaling molecule in 
the activation of the Arc system [65], adding a further level of 
complexity to the ArcBA-mediated metabolic responses in E. coli. 
Vemuri et al. [101] reasoned that if cells are provided with an 
efficient mechanism to reduce high NADH/NAD+ ratios (that result 
in production of acetate) while preventing the Arc-dependent 
repression of the TCA cycle, additional carbon skeletons would be 
available for both biomass generation and recombinant protein 
production. The authors constructed an E. coli arcA mutant that 
overexpresses a NADH oxidase from Streptococcus pneumoniae 
[101]. Using steady-state, D-glucoselimited chemostat cultures, they 
were able to expose a strong correlation between acetate formation 
and the intracellular redox ratio [102]. Moreover, delay of acetate 
overflow in the engineered strain allowed to attain a titer of the model 
recombinant protein -galactosidase ca. 2-fold higher than that of the 
wild-type strain. 
Recent studies also allowed to explain a particular phenotype of 
the industrially-relevant E. coli BL21. By comparing the biomass 
yields and 13C-metabolic flux analysis of a arcA iclR double 
knock-out constructed in two genetic backgrounds (E. coli MG1655 
and BL21) grown either under D-glucose-excess or D-glucose-limited 
conditions, it turned out that the metabolic similarity between both 
strains arise from mutations that affect both arcA expression and the 
promoter region of the gene encoding IclR, a local regulator which 
controls the transcription of the glyoxylate pathway genes within the 
aceBAK operon [103,104]. These redox MCFs proved adequate for 
industrial purposes, as isocitrate was directly converted into succinate 
and malate, preventing carbon loss as CO2 and considerably 
diminishing the synthesis of acetate. 
 
OTHER METABOLIC ENGINEERING STRATEGIES 
FOR THE MANIPULATION OF THE REDOX 
HOMEOSTASIS 
 
Although several strategies and approaches complementary to 
those discussed in this mini-review have been explored for the 
manipulation of the redox state in MCFs designed for reduced 
biochemicals production, some of them deserve special attention 
because of their relevance. A recent study by Bidart et al. [105] 
exploited the possibility of using partial deletions in the ArcB 
regulator in order to obtain graded phenotypes. This constituted a 
first-case study on the effects of confined deletions in a global 
regulator (as opposed to the elimination of the entire gene) for 
metabolic engineering endeavors. A gradual impact of these deletions 
on the distribution of metabolic fluxes was observed under anoxic 
growth conditions, and most of the changes could be traced to the 
redox state of the cells. The incremental differences observed both in 
the redox homeostasis and central carbon fluxes among the mutants 
make them potentially attractive MCFs for biotechnological purposes. 
Other studies dealt with the direct manipulation of the redox state 
of the cell by stimulating high NAD(P)H/NAD(P)+ ratios. For 
instance, Zhou et al. [106] manipulated the transcriptional control of 
the genes encoding the components of the pyruvate dehydrogenase 
complex by using promoters of the pfl genes. Doubling of the 
reducing power output was achieved when D-glucose was converted 
into acetyl-CoA through the EMP pathway followed by oxidation of 
pyruvate by the anoxically-active pyruvate dehydrogenase complex 
(i.e., D-glucose  2acetyl-CoA + 4NADH). Martínez et al. [107] 
constructed a recombinant E. coli strain by replacing gapA, encoding 
the native NAD+-dependent glyceraldehyde-3-phosphate 
dehydrogenase, with gapC from Clostridium acetobutylicum, which 
encodes a NADP+-dependent glyceraldehyde-3-phosphate 
dehydrogenase. The recombinant produced 2 moles of NADPH, 
instead of NADH, per mole of D-glucose consumed. The 
effectiveness of the NADPH enhancing system was analyzed in the 
recombinant MCFs by evaluating the production of lycopene and -
caprolactone, the synthesis of which consumes NADPH, as model 
systems. The authors elegantly demonstrated that the synthesis of 
both heterologous molecules was favored in the recombinant MCFs 
when compared to the parental strain. Another interesting approach 
reported by Zhu et al. [108] showed that controlled respiration levels 
in E. coli can be exploited to allow wide operating windows in terms 
of O2 availability, thus allowing for the formation of reduced 
bioproducts even under fully oxic conditions. The authors added 
different amounts of coenzyme Q1 (an ubiquinone analogue) to oxic 
cultures of ubiCA mutant strains (i.e., lacking the critical enzymes 
involved in ubiquinone synthesis). In this case, the target metabolite 
was ethanol, using glycerol as the carbon source. The recombinant 
MCF, carrying the pdc and adhB genes from Zymomonas mobilis, 
produced high ethanol titers under conditions in which the original 
strain was not able to synthesize any reduced by-product derived from 
the oxic glycerol catabolism. 
 
SUMMARY AND OUTLOOK 
 
From the data presented in the preceding sections, it is clear that 
the relative lack of knowledge on the cellular wiring of regulatory 
networks under conditions relevant to both laboratory and industrial 
applications represents one of the most significant hurdles to be 
overcome for the efficient design of MCFs. However, a suite of 
different strategies that could offer interesting alternatives to tackle 
this issue has emerged in recent years. 
In the first place, genome-scale and specific metabolic models are 
starting to play an important role in deciphering the cellular and 
metabolic characteristics of microbial cells in silico [109,110]. The 
number of genome-scale metabolic models is rapidly increasing and 
their quality is also improving. Strategies devised to incorporate 
experimental data, such as high-throughput -omics data, have also 
been developed to enhance the quality and the accuracy of metabolic 
models. In close connection with these in silico approaches, synthetic 
biology is rapidly emerging as a relevant field for the rational 
manipulation of MCFs. Synthetic biology can be defined as the 
engineering of biology, i.e., the synthesis of complex, biologically-
based (or inspired) systems, which could display functions that do not 
exist in nature. The possibility of developing an entirely synthetic host 
for efficient target-molecule production presents great opportunities 
for further research. In this sense, synthetic biology can significantly 
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advance metabolic engineering by both contributing tools (e.g., 
minimal genome hosts, vectors, genetic controllers, and characterized 
enzymes), and by aiding potential interventions to metabolism at one 
or many of the following levels: [i] enhancement in the rate of 
substrate uptake, [ii] reduction of flux(es) to undesirable by-products, 
and enhancement of precursors and cofactor availability, [iii] 
introduction of relevant heterologous pathway(s) and optimization of 
the activity of its constituent enzymes, and [iv] export of the product 
to the extracellular medium in order to shift the concentration 
equilibrium towards product formation. 
This exciting and extremely dynamic scenario will certainly lead to 
the development of better strategies to manipulate central and 
peripheral pathways to enhance the production of reduced 
biochemicals and other molecules of industrial interest. 
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